Skip to main content
. 2016 Oct 10;16:778. doi: 10.1186/s12885-016-2838-4

Fig. 2.

Fig. 2

Cumulative incidence of lung cancer in ICS users and the comparison cohorts stratified by the presence of non-lung infection (a), TB (b), pneumonia (c), and TB+ pneumonia (d). ICS, inhaled corticosteroid; TB, tuberculosis